Augmentation of antipsychotic partial responders with tetrabenazine

Trial Profile

Augmentation of antipsychotic partial responders with tetrabenazine

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jul 2012

At a glance

  • Drugs Tetrabenazine (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jul 2012 Actual end date (1 Jan 2006) added as reported by ClinicalTrials.gov.
    • 05 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Dec 2011 Endpoint 'Clinical-Global-Impressions-scale' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top